The PrEP pill has been a widely adopted method for reducing HIV transmission among White gay and bisexual males, but not as much among other vulnerable groups.

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

A potential compromise would keep PrEP covered by insurers and employers as a case that would overrule federal protection for HIV preventative care moves through the courts.

This new FDA-approved shot is designed to break down the barriers that have kept too many people from accessing PrEP.

A case that is winding its way through the court system might push the cost of HIV pre-exposure prophylaxis to levels that are unaffordable for many.

The prices for HIV-prevention medication PrEP can range from 50 cents a day to north of $18,000 annually.

More encouraging news has been announced about the new, twice-yearly PrEP injection currently undergoing trials. Lenacapavir is already in use as a treatment for HIV.

Although the initial challenge was specifically regarding PrEP, the case calls into question the validity of all decisions made by the U.S. Preventive Services Task Force, which sets preventive ...

PrEP is a once-daily pill that dramatically reduces the risk of HIV transmission when taken consistently.

Antiretroviral therapy has transformed HIV from a fatal diagnosis into a manageable chronic condition, and pre-exposure prophylaxis (PrEP) is an effective tool for helping to prevent new cases.

The Phase III trial compared a twice-yearly injection of the antiviral drug lenacapavir to a widely used daily PrEP pill that contains two different antiviral drugs.